Gilead Sciences, Inc. - Jun 30, 2025 SCHEDULE 13G/A Report for Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

Filing Manager: GILEAD SCIENCES, INC.
Reporting Manager: GILEAD SCIENCES, INC.
Security: Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: XLO
Shares outstanding: 53.3M shares
Disclosed Ownership: 10.6M shares
Ownership: 19.9%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 04:42 PM
Date of event: Jun 30, 2025
Previous filing: Dec 19, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GILEAD SCIENCES, INC.	19.9%	10.6M	10.6M	0	/s/ Andrew D. Dickinson	Executive Vice President and Chief Financial Officer